Labiana Health, S.A. (BME:LAB)
6.35
-0.10 (-1.55%)
At close: Jul 17, 2026
Labiana Health Revenue
In the year 2025, Labiana Health had annual revenue of 76.44M EUR with 13.46% growth. Labiana Health had revenue of 39.93M in the quarter ending June 30, 2025, with 36.80% growth.
Revenue
76.44M
Revenue Growth
+13.46%
P/S Ratio
0.69
Revenue / Employee
194.02K
Employees
394
Market Cap
52.70M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 76.44M | 9.07M | 13.46% |
| Dec 31, 2024 | 67.37M | 7.68M | 12.86% |
| Dec 31, 2023 | 59.70M | -1.06M | -1.74% |
| Dec 31, 2022 | 60.76M | 1.31M | 2.21% |
| Dec 31, 2021 | 59.44M | -658.32K | -1.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.44B |
| Almirall | 1.12B |
| Laboratorios Farmaceuticos Rovi | 741.09M |
| Faes Farma | 674.06M |
| Laboratorio Reig Jofre | 335.01M |
| Prim, S.A. | 251.89M |
| Atrys Health | 144.31M |
| Pangaea Oncology | 16.73M |